Vanda Pharmaceuticals Affirms FY2026 Sales Guidance of $240.000M-$290.000M vs $262.154M Est
Vanda Pharmaceuticals (NASDAQ: VNDA ) affirms FY2026 sales outlook from $240.000 million-$290.000 million to $240.000 million-$290.000 million vs $262.154 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.